BIND Therapeutics' IPO

BIND Therapeutics raised a round of funding on September 20, 2013. Investors include Public.

BIND Therapeutics, formerly BIND Biosciences, is a biopharmaceutical company leveraging its medicinal nanoengineering platform to design, engineer and manufacture targeted therapeutics. Medicinal nano…

Articles about BIND Therapeutics' IPO: